article thumbnail

Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More

Xconomy

Those drugs have now become the center of a patent dispute between the Foster City, CA, drug maker and the federal government. This week, the government filed a patent infringement suit in federal court against Gilead (NASDAQ: GILD ).

Patents 65
article thumbnail

10 Key Business Founder Checks Needed Before The Plan

Startup Professionals Musings

You may dream of developing a new silicon chip technology, but a bit of research should tell you that most disruptive solutions take billions in investment, and more time than you can afford for acceptance. You need intellectual property , such as a patent, trade secret, or process expertise that will be a barrier that you can defend.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

After Decades of R&D, Bose Amps Up VC Deals in AR, Wearables, Wellness

Xconomy

For the first 50 years of its existence, Bose Corporation invested primarily in in-house research and development to produce its lineup of high-end headphones, speakers, and other audio technologies.

article thumbnail

6 Steps To Move From Inspiration To Business Reality

Startup Professionals Musings

I suggest you use social media, blogging, crowdfunding, or documented research to quantify a real demand from people who can afford it, and don’t have a better alternative already out there. Any startup with no patents, trade secrets, or other secret sauce is very high risk today.

Ideas 94
article thumbnail

Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More

Xconomy

What are the implications of a Trump administration for life science research, or next year’s reauthorization of the Prescription Drug User Fee Act? —Check out these stories from Nature , Reuters , TheStreet.com , and Forbes for more on the potential election fallout for life science companies, scientific research, and Obamacare.

Patents 87
article thumbnail

“Stigma is Going Away”: Cannabis IP is Thorny, But Not Impossible

Xconomy

How do research and development teams create new products. But with corporations and mom-and-pop players alike wanting to get in on that “green rush”— valued at $146.4 billion globally by 2025 and $25 billion in the U.S. alone—how does an innovator protect intellectual property in a quasi-legal industry?

IP 91
article thumbnail

First Ever Startup Weekend Orange County Live!

Tech Zulu Event

Maneesh began his career conducting research at Brown University’s Experimental Pathology Lab to determine the effects of HIV on the Vitamin D pathway. He blogs at startup-marketing.com. Dr. Sudek’s primary research interests are in the area of entrepreneurial finance, entrepreneurial leadership, and team leadership.